• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Abbott Laboratories

Abbott Laboratories

Abbott Laboratories ABT 4 Star

Last Price$41.46Day Change (%)1.47%
Open Price$40.85Day Change ($)0.60
Day Range40.67–41.5152-Week Range35.65–44.20

As of Mon 10/20/2014 03:40 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Abbott Laboratories ABT Announces Acquisition of CFR Pharmaceuticals

    Abbott Laboratories ABT Announces Acquisition of CFR Pharmaceuticals

  2. AbbVie formally scuttles deal to buy Shire

    AbbVie formally scuttles deal to buy Shire

  3. Top 10 Buys and Sells by the Ultimate Stock-Pickers

    A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.

  4. Diversifying in a Shrinking World

    Simple formulas for foreign exposure lose luster.

  5. AbbVie Board Recommends Stockholders Vote Against Shire Transaction

    AbbVie Board Recommends Stockholders Vote Against Shire Transaction

  6. Research and Markets: Global Partial Seizure Clinical Trials Review, H2, 2014

    Research and Markets: Global Partial Seizure Clinical Trials Review, H2, 2014

  7. Bad Investor Behavior: Overemphasizing Experience

    Abbott Labs ABT had a strong showing at the American College of Cardiology's annual meeting this weekend, but the news was less positive for Boston Scientific BSX and partner Angiotech ANPI. Abbott revealed data from a head-to-head trial that demonstrated its Xience V drug-eluting stent performed ...

  8. Research and Markets: Global Low-Calorie Food Market Outlook 2019 - Key Analysis of the $7.4 Billion Industry

    Research and Markets: Global Low-Calorie Food Market Outlook 2019 - Key Analysis of the $7.4 Billion Industry

  9. Research and Markets: Global Biological Drugs Market Outlook 2020

    Research and Markets: Global Biological Drugs Market Outlook 2020

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.